General Surgery
Impact of Cholecystitis Treatment on Continuation of Cancer Therapy: Insights from a Decade-long Institutional Study
This study evaluates how treatment for cholecystitis affects the timely resumption of cancer therapy, highlighting that half of cancer patients return to therapy within six weeks, with hematologic malignancies and drainage procedures linked

